These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 790134)
1. [Modifying factors in carciac glycoside therapy]. Krebs R Med Klin; 1976 Oct; 71(42):1759-70. PubMed ID: 790134 [No Abstract] [Full Text] [Related]
2. [Optimization of therapy using cardiac glycosides]. Ziesenhenn K; Behn P Z Gesamte Inn Med; 1978 Nov; 33(22):830-3. PubMed ID: 746673 [TBL] [Abstract][Full Text] [Related]
3. [Clinical trial of a new cardiac glycoside: cd.412]. Gentile C; Gentile JH Prensa Med Argent; 1972 Jun; 59(22):841-8. PubMed ID: 5051118 [No Abstract] [Full Text] [Related]
5. [Clinical study of meproscillarin rates of inactivation and persistence, bioavailability and maintenance dose]. Herken H; Brandes J Arzneimittelforschung; 1978; 28(3a):557-60. PubMed ID: 580590 [TBL] [Abstract][Full Text] [Related]
6. [Cardiac glycoside therapy]. Born H Folia Clin Int (Barc); 1969 Nov; 17(11):534-45. PubMed ID: 5803723 [No Abstract] [Full Text] [Related]
7. [Treatment of congestive heart failure with cardiac glycosides. I. New theses in the principles of treatment]. Tomov I Vutr Boles; 1980; 19(6):7-14. PubMed ID: 7210653 [No Abstract] [Full Text] [Related]
9. [Therapy of chronic heart failure in old age]. Polzien P; Polzien E Dtsch Med Wochenschr; 1980 Aug; 105(35):1201-2. PubMed ID: 7428635 [No Abstract] [Full Text] [Related]
10. Current drug therapy: cardiac glycosides. Am J Hosp Pharm; 1978 Dec; 35(12):1495-507. PubMed ID: 362913 [TBL] [Abstract][Full Text] [Related]
11. [The therapy of cardiac insufficiency using Theo-Alvonal]. Kettermann W Munch Med Wochenschr; 1968 Jan; 110(4):228-32. PubMed ID: 5695033 [No Abstract] [Full Text] [Related]
12. [Directed glycoside therapy of manifest heart insufficiency]. Storz H Med Klin; 1971 Apr; 66(16):587-92. PubMed ID: 5552925 [No Abstract] [Full Text] [Related]
13. [Introduction to clinical pharmacodynamics and pharmacokinetics of cardiac glycosides]. Kudrin AN; Namakanov BA; Davydova ON Sov Med; 1981; (11):70-4. PubMed ID: 7038899 [No Abstract] [Full Text] [Related]
14. [Therapy of chronic cardiac insufficiency with cardiac glycosides]. Bonelli J Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995 [No Abstract] [Full Text] [Related]
15. [Therapy with cardiac glycosides]. Simon H Hippokrates; 1976 Feb; 47(1):30-52. PubMed ID: 783095 [No Abstract] [Full Text] [Related]
16. [Cardiac glycoside therapy]. Michel D Fortschr Med; 1971 Aug; 89(24):917-21. PubMed ID: 4262966 [No Abstract] [Full Text] [Related]
17. [Frequent errors in the therapy of heart disease]. Heinecker R Wien Med Wochenschr; 1982 Nov; 132(22):531-6. PubMed ID: 6132496 [No Abstract] [Full Text] [Related]
18. [On the therapy of heart insufficiency with the pure glycoside Proscillaridin A]. Lampe W; Tergau G Med Welt; 1966 Apr; 18():1034-9. PubMed ID: 5955405 [No Abstract] [Full Text] [Related]
19. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure]. Denisiuk VI; Shkliar MB Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733 [No Abstract] [Full Text] [Related]
20. [Pharmacokinetics and drug interactions of digitalis glycosides]. Kolenda KD Med Klin; 1976 Aug; 71(34):1313-20. PubMed ID: 785179 [No Abstract] [Full Text] [Related] [Next] [New Search]